Page 174 - MEMORIA ANUAL 2021

MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GEMFIN
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
facio M, Cervantes KSQ, Serrano MS, Carreno-Tarragona G, Sobas MA, Lunghi F, Patriarca A, Elorza BN, Angona A, Mazo EM, Koschmieder S, Ruggeri M, Cuevas B, Hernández-Boluda JC, Abadía EL, Cirici BX, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto-García N, Bellini M, Betti S, De Stefano V, Harrison C, Rambaldi A .
• CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review.
Curr Res Transl Med. 2021 Oct;69(4):103304. doi: 10.1016/j.retram.2021.103304. Hernani R, Sancho A, Amat P, Hernández-Boluda JC, Pérez A, Piñana JL, Carretero C, Goterris R, Gómez M, Saus A, Ferrer B, Teruel AI, Terol MJ, Solano C .
• Among classic myeloproliferative neoplasms, essential thrombocythemia is associ- ated with the greatest risk of venous thromboembolism during COVID-19.
Blood Cancer J. 2021 Feb 4;11(2):21. doi: 10.1038/s41408-021-00417-3.
Barbui T, De Stefano V, Álvarez-Larrán A, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Ferrari A, Cancelli V, Elli EM, Andrade-Campos MM, Kabat MG, Kiladjian JJ, Palandri F, Benevolo G, García-Gutiérrez V, Fox ML, Foncillas MA, Morcillo CM, Rumi E, Osorio S, Papadopoulos P, Bonifacio M, Cervantes KSQ, Serrano MS, Carreno-Tarragona G, Sobas MA, Lunghi F, Patriarca A, Elorza BN, Angona A, Mazo EM, Koschmieder S, Carli G, Cue- vas B, Hernández-Boluda JC, Abadía EL, Cirici BX, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto-García N, Bellini M, Betti S, Harrison C, Rambaldi A, Vannucchi AM .
• The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.
Eur J Haematol. 2021 Mar;106(3):371-9. doi: 10.1111/ejh.13561.
Pérez Encinas MM, Sobas M, Gómez-Casares MT, Abuin Blanco A, Noya Pereira MS, Raya JM, Andrade-Campos MM, Álvarez Larrán A, Lewandowski K, Łukasz S, Hernández Bo- luda JC, Ferrer-Marín F, Fox ML, Gołos A, Gasior Kabat M, Magro Mazo E, Czyż A, Martín Martín A, Bellosillo Paricio B, Quinteiro García C, González Martín JM, Stuckey R .
• European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party.
Curr Res Transl Med. 2021 Jan;69(1):103267. doi: 10.1016/j.retram.2020.08.003. McLornan DP, Sirait T, Hernández-Boluda JC, Czerw T, Hayden P, Yakoub-Agha I .
• Outcomes following second allogeneic haematopoietic cell transplantation in pa- tients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT.
174